Patrick W Serruys, Norihiro Kogame, Yuki Katagiri, Rodrigo Modolo, Pawel E Buszman, Andrés Íñiguez-Romo, Javier Goicolea, David Hildick-Smith, Andrzej Ochala, Dariusz Dudek, Jan J Piek, Joanna J Wykrzykowska, Javier Escaned, Adrian P Banning, Vasim Farooq, Yoshinobu Onuma
AIMS: The purpose of the study was to investigate whether the favourable outcomes of state-of-the-art PCI in the SYNTAX II trial, demonstrated at one year, were maintained at two-year follow-up. METHODS AND RESULTS: The SYNTAX II study was a multicentre, single-arm study that investigated the impact of a contemporary PCI strategy on clinical outcomes in 454 patients with de novo three-vessel coronary artery disease, without left main disease. Clinical outcomes in SYNTAX II were compared to the predefined PCI (SYNTAX-I PCI) and coronary artery bypass graft (SYNTAX-I CABG) cohorts from the landmark SYNTAX trial (SYNTAX-I), selected on the basis of equipoise for long-term (four-year) mortality utilising the SYNTAX score II...
June 12, 2019: EuroIntervention